新乳业(002946) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 1,511,653,716, representing a year-on-year increase of 13.03%[8] - Net profit attributable to shareholders was CNY 74,631,089, a year-on-year increase of 1.84%[8] - Net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 9.81% to CNY 60,669,431[8] - Basic earnings per share decreased by 10.00% to CNY 0.09[8] - Weighted average return on equity decreased by 1.58% to 3.82%[8] - Total operating revenue for the third quarter of 2019 was CNY 1,511,653,716.00, an increase from CNY 1,337,428,689.00 in the same period of 2018[75] - Total operating costs for the third quarter of 2019 were CNY 1,466,554,929.00, up from CNY 1,283,078,426.00 year-over-year[75] - Net profit for the third quarter of 2019 reached CNY 77,343,483.00, compared to CNY 75,548,287.00 in the previous year[78] - The total operating revenue for the current period reached ¥4,221,608,178.00, an increase from ¥3,725,422,706.00 in the previous period, representing a growth of approximately 13.4%[90] - The net profit for the current period was ¥2,343,416.00, down from ¥3,963,537.00 in the previous period, reflecting a decrease of approximately 41%[86] - The total profit for the current period is $201,208,775, compared to $196,350,155 in the previous period, indicating an increase of about 2.4%[93] - The net profit for the current period is $185,511,352, up from $178,977,695 in the previous period, representing a growth of approximately 3.3%[93] Assets and Liabilities - Total assets increased by 24.27% to CNY 5,270,062,520 compared to the end of the previous year[8] - Net assets attributable to shareholders increased by 29.77% to CNY 1,893,547,029 compared to the end of the previous year[8] - Cash and cash equivalents increased by 47.08% to RMB 44,801.06 million, primarily due to the net proceeds from the public issuance of A-shares and the addition of RMB 48.62 million from a new subsidiary[22] - Accounts receivable rose by 34.72% to RMB 48,397.51 million, driven by increased sales through direct sales channels with a credit period for customers[25] - Short-term borrowings increased by 47.29% to RMB 157,743.58 million, reflecting the company's need for additional funds to support operational growth[29] - Total liabilities as of September 30, 2019, amounted to CNY 3,289,783,510, up from CNY 2,698,733,022, reflecting an increase of approximately 21.9%[61] - The company's total assets reached CNY 5,270,062,520, compared to CNY 4,240,951,032 at the end of 2018, indicating a growth of around 24.3%[64] - The total liabilities to equity ratio as of September 30, 2019, was approximately 1.65, compared to 1.85 at the end of 2018, indicating a decrease in financial leverage[61] Cash Flow - Net cash flow from operating activities decreased by 26.08% to CNY 98,049,091[8] - Net cash flow from financing activities surged by 318.31% to RMB 80,058.21 million, mainly due to increased cash inflow from the public issuance of A-shares and higher net borrowings[38] - The total cash flow from operating activities for the current period is $4,717,687,657, compared to $4,247,176,241 in the previous period, reflecting an increase of about 11.1%[100] - The net cash flow from operating activities was 313,597,727.00, a decrease from 355,516,312.00 in the previous period, reflecting a decline of approximately 11.5%[103] - The net cash flow from financing activities increased significantly to 800,582,092.00, compared to a negative cash flow of -366,712,592.00 in the prior period[106] Investments and Expenses - The company invested RMB 709,151.51 million in equity securities, with a fair value loss of RMB 97,394.46 million recorded[43] - Research and development expenses for the third quarter of 2019 were CNY 6,928,073.00, down from CNY 10,338,746.00 in the same period of 2018[75] - The research and development expenses for the current period amounted to ¥20,245,940.00, a decrease from ¥24,610,709.00 in the previous period, showing a reduction of about 17.5%[90] - The company has incurred research and development expenses of $2,370,032, which is an increase from $1,644,361 in the previous period, representing a growth of approximately 43.5%[97] Shareholder Information - The total number of shareholders at the end of the reporting period was 29,504[12] - The capital reserve increased by 146.83% to RMB 53,947.96 million, reflecting the net proceeds from the public issuance of A-shares[30] - The company's retained earnings as of September 30, 2019, were CNY 576,635,984, up from CNY 450,205,482, representing an increase of approximately 28.1%[64]